论文部分内容阅读
缺血性心、脑血管疾病与血管本身结构病变及血流动力学变化的关系已有较多研究。近年认识到血液流变性及血小板聚集性改变亦为影响病情及预后的重要因素。本文初步报导我省新型活血化淤药—阿魏酸派嗪(心血康Ⅰ)的临床疗效及血液流变学效应。病例和方法一、治疗对象:全部病例系1983~1985期间我
There has been more research on the relationship between ischemic heart and cerebrovascular diseases and the structural changes of blood vessels and their hemodynamic changes. In recent years, he realized that changes in blood rheology and platelet aggregation also affect the condition and prognosis of the important factors. This article initially reported the new type of blood circulation in our province - ferulic acid-based drug (Xingsukang Ⅰ) clinical efficacy and hemorheological effects. Cases and methods First, the treatment of patients: all cases of 1983 to 1985 period I